Calix Ltd. (CXL) AI Stock Analysis

• Market Cap: AU$68.69M
• Dividend Yield: N/A
• Average Volume (3M): 285.52K
• Price to Earnings (P/E): ―
• Beta (1Y): 1.61
• Revenue Growth: 15.24%
• EPS Growth: 8.35%
• Country: AU
• Employees: 155
• Sector: Basic Materials
• Sector Strength: 68
• Industry: Chemicals - Specialty
• EPS (TTM): -0.14
• Shares Outstanding: 214,646,600
• 10 Day Avg. Volume: 234,608
• 30 Day Avg. Volume: 285,525
• PEG Ratio: -1.07
• Price to Book (P/B): 7.15
• Price to Sales (P/S): 0.00
• P/FCF Ratio: -24.50
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: AU$1.70
• Price Target Upside: 466.67% Upside
• Rating Consensus: Moderate Buy
• Number of Analyst Covering: 0

• Rating: 47 Neutral
• Price Target: AU$0.50 ▲(66.67%Upside)

The overall score is driven by financial performance indicating revenue growth but significant profitability challenges. Technical analysis suggests bearish trends, while valuation metrics show negative profitability with no income support. The absence of earnings call data and corporate events does not provide additional context.

Calix Ltd. Business Overview & Revenue Model

Company Description

Calix Ltd. (CXL) is a technology company that specializes in developing and commercializing patented industrial solutions aimed at reducing carbon emissions, improving sustainability, and enhancing efficiency across various sectors. The company's core offerings include innovative technologies for mineral processing, water treatment, and carbon capture, serving industries such as agriculture, wastewater management, and construction.

How the Company Makes Money

Calix Ltd. generates revenue primarily through the sale and licensing of its proprietary technologies and solutions. The company earns income by providing tailored solutions to industrial clients seeking to improve their environmental footprint and operational efficiency. Key revenue streams include direct sales of products and systems, licensing agreements where clients pay for the use of Calix's technology, and service contracts for ongoing maintenance and support. Significant partnerships with industry leaders and government entities often bolster these revenue streams, enabling Calix to expand its market reach and enhance its technological offerings.

Calix Ltd. Financial Statement Overview

Summary

Calix Ltd. shows positive revenue growth but faces challenges in profitability and cash flow. The balance sheet indicates low leverage, yet the company's struggle to maintain profitability and generate positive cash flows could impact future growth.

Income Statement

Calix Ltd. has experienced revenue growth from $18.6M to $24.2M in the recent year, indicating a positive trajectory. However, the company has consistently reported negative net income and gross profit margins, signaling ongoing operational and profitability challenges. The negative EBIT and EBITDA margins further highlight profitability issues.

Balance Sheet

The company's balance sheet shows a relatively stable debt-to-equity ratio, with low total debt compared to equity, suggesting prudent leverage management. However, stockholders' equity has decreased over the year, indicating potential financial strain. The equity ratio is strong, highlighting a solid equity base relative to total assets.

Cash Flow

Calix Ltd. shows a decline in free cash flow, with negative growth in recent years. Operating cash flow remains negative, indicating cash utilization challenges. The free cash flow to net income ratio is unfavorable, reflecting insufficient cash returns relative to earnings.

Breakdown
TTM	Jun 2024	Jun 2023	Jun 2022	Jun 2021	Jun 2020
Income Statement		Total Revenue
25.52M	24.19M	18.60M	18.47M	19.21M	14.06M
	Gross Profit
3.02M	10.29M	-2.40M	1.01M	1.86M	650.64K
	EBIT
-44.71M	-38.92M	-34.07M	-18.97M	-15.74M	-12.82M
	EBITDA
-27.09M	-19.52M	-25.03M	-12.69M	-11.19M	-9.32M
	Net Income Common Stockholders
-24.76M	-25.26M	-23.19M	-16.34M	-9.11M	-7.08M
Balance Sheet		Cash, Cash Equivalents and Short-Term Investments
36.13M	42.96M	74.47M	24.98M	15.13M	11.08M
	Total Assets
117.84M	112.40M	127.51M	61.21M	51.62M	42.76M
	Total Debt
2.92M	3.26M	1.32M	1.47M	1.29M	684.20K
	Net Debt
-32.91M	-39.70M	-73.15M	-23.51M	-13.84M	-10.40M
	Total Liabilities
26.14M	28.39M	22.55M	16.41M	13.48M	16.53M
	Stockholders Equity
92.10M	83.79M	103.73M	43.49M	38.15M	26.23M
Cash Flow		Free Cash Flow
-32.66M	-33.13M	-30.29M	-12.76M	-15.06M	3.68M
	Operating Cash Flow
-15.17M	-13.68M	-17.26M	-3.74M	-8.12M	10.25M
	Investing Cash Flow
-14.71M	-17.55M	-13.03M	13.83M	-6.94M	-16.19M
	Financing Cash Flow
17.91M	-280.00K	79.77M	-232.33K	19.11M	12.60M

Calix Ltd. Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 0.30
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Negative
• MACD: Positive
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For AU:CXL, the sentiment is Negative. The current price of 0.3 is below the 20-day moving average (MA) of 0.35, below the 50-day MA of 0.36, and below the 200-day MA of 0.68, indicating a bearish trend. The MACD of -0.02 indicates Positive momentum. The RSI at 36.25 is Neutral, neither overbought nor oversold. The STOCH value of 21.36 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for AU:CXL.

Calix Ltd. Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
ORA	75 Outperform	AU$2.38B	12.81	4.78%	5.39%	-13.90%	0.56%
RUL	73 Outperform	AU$704.85M	107.80	11.59%	―	9.76%	-28.92%
BPT	54 Neutral	$3.04B	33.04	2.70%	4.42%	6.43%	―
Sector *	51 Neutral	$2.04B	-1.21	-21.10%	3.95%	2.90%	-30.45%
LKE	48 Neutral	AU$54.66M	―	-19.25%	―	―	65.04%
CXL	47 Neutral	AU$68.69M	―	-26.71%	―	15.24%	8.35%
E25	40 Underperform	AU$43.44M	―	-16.88%	―	-67.72%	65.78%

Calix Ltd. Corporate Events

Calix Ltd. Releases General Overview and Investment Disclaimers

Calix Ltd. has released a presentation providing a general overview of its operations and financial data as of June 2025. The document emphasizes that it is not a financial product advice or an offer to acquire securities, and highlights the risks associated with investing in Calix. The presentation includes disclaimers about forward-looking statements and the lack of guarantees regarding future performance, urging potential investors to seek personalized legal and financial advice.

The most recent analyst rating on (AU:CXL) stock is a Buy with a A$2.40 price target. To see the full list of analyst forecasts on Calix Ltd. stock, see the AU:CXL Stock Forecast page.

Calix Subsidiary Leilac Pauses U.S. Projects Amid Funding Uncertainty

Calix Limited announced that its subsidiary, Leilac, is scaling back its U.S. projects due to ongoing reviews of government spending by the Trump administration. The uncertainty surrounding U.S. Department of Energy funding has led Leilac to reduce resources and costs to maintain a cash-neutral position. Despite this, Calix and Leilac are prepared to expand their project capacity in the U.S. once funding is confirmed, while continuing to focus on opportunities in Europe and Asia Pacific.

The most recent analyst rating on (AU:CXL) stock is a Buy with a A$2.00 price target. To see the full list of analyst forecasts on Calix Ltd. stock, see the AU:CXL Stock Forecast page.

Calix Limited to Host Informative Webinar on Environmental Technology

Calix Limited announced an upcoming webinar hosted by Sharewise, where CEO Phil Hodgson will provide an overview of the company. This event aims to introduce Calix’s operations and technology to a broader audience, reflecting the company’s commitment to addressing global decarbonisation challenges and enhancing its industry positioning.

The most recent analyst rating on (AU:CXL) stock is a Hold with a A$0.80 price target. To see the full list of analyst forecasts on Calix Ltd. stock, see the AU:CXL Stock Forecast page.

Calix Water Treatment Products Exempt from U.S. Tariffs

Calix Limited announced that its water treatment products sold in the U.S. are exempt from the tariffs imposed by the Trump administration, due to compliance with the United States-Mexico-Canada Agreement (USMCA). This exemption is significant for Calix as its Magnesia business, which heavily relies on U.S. sales, constitutes a major portion of the company’s revenue. The exemption positions Calix favorably in the U.S. market, especially given the country’s reliance on magnesia imports, predominantly from China, which are subject to tariffs.